Ocugen, Inc.
OCGN
Jodie situation report
Ocugen, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 17 directly disclosed connections are confirming.
- OCGN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if OCGN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind OCGN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
KPRXFiling-linked namepartnerMar 4, 2026 ▾
“Hoffmann-La Roche AG ("Roche AG"), Kiora Pharmaceuticals, Inc., Genentech, Inc.”
LCTXFiling-linked namepartnerMar 4, 2026 ▾
“Hoffmann-La Roche AG ("Roche AG"), Kiora Pharmaceuticals, Inc., Genentech, Inc.”
LSHGYFiling-linked namepartnerAug 4, 2025 ▾
“Louis, pursuant to which we licensed the rights to develop, manufacture, and commercialize a mucosal COVID-19 vaccine for the prevention of COVID-19 in the United States, Canada, Europe, Japan, South Korea, Australia, China, and Hong Kong.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 16 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
OCGN is currently a Follower in the organic co-movement group Healthcare & Credit Tech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for OCGN; it is not active in the latest market snapshot.